SILO Needs To Be On Level 2 Today

  My Single Highest Conviction Idea Every Morning

*together with SILO Pharma Inc

Good morning traders, let’s get ready to rummmmmmble!!!

SILO is one that needs to be on your Level 2 today.

This is a small-cap biotech name that can move fast when volume shows up, and right now there are a few reasons traders should have it on radar.

The latest headline is the big one. Silo Pharma just announced it is advancing its SPC-15 PTSD program with a new drug-device robustness study ahead of a planned FDA Type C meeting request. That matters because SPC-15 is the company’s lead intranasal PTSD treatment, and this study is designed to test the performance and stability of its nose-to-brain delivery system.

That comes right after Silo reported positive stability data for SPC-15, which the company said supports the program moving toward a first-in-human clinical trial. For a small biotech stock, traders love seeing a steady chain of development updates because each milestone can create fresh attention and volume.

The company is focused on underserved areas like PTSD, stress-induced anxiety, chronic pain and central nervous system disorders. That puts SILO in a very active healthcare lane where even smaller companies can catch strong speculative interest if traders believe the pipeline is moving closer to human trials.

Fundamentally, this is still a developmental-stage biotech, so it is not a traditional revenue story yet. This is more of a catalyst and pipeline story. But that is exactly why traders watch names like this closely. A small market cap, limited float, Nasdaq compliance regained recently, and fresh biotech headlines can create the type of volatility penny stock traders look for.

SILO also recently regained compliance with Nasdaq’s minimum bid price requirement, which removes one overhang that had been sitting on the stock. That does not guarantee anything, but it is a positive step for a company trying to keep attention on its pipeline and regain market confidence.

Technically, SILO has been trying to stabilize after a major reset in the stock. The key levels I would watch today are the recent range around the $6 area, then any push toward the $6.50 area and above. If volume starts building and Level 2 starts showing aggressive bid support, this could become a momentum watch very quickly.

The big thing today is simple: watch volume, watch Level 2, and watch whether buyers step in above recent support. If SILO starts getting real volume behind the latest biotech catalyst, this is the kind of low-float name that can get attention fast.

As always, this is not a buy or sell recommendation. SILO is a volatile small-cap biotech, so risk management matters. But with fresh pipeline news, Nasdaq compliance back in place, and a small-float setup, this is absolutely one traders should have on radar today.

I hope you all have a great day and if you want penny stock alerts from myself and my trading team plus stock education, jump into the War Room by clicking on the image below. It’s absolutely FREE for you to come join the room!

 P.S. If you would like to see if you have any credits you can apply to any of my services, please reach out to our team at [email protected] or call us at 800-585-4488.